Robert T. Lyons,James A. Burke,Michael R. Robinson
申请号：
US11753419
公开号：
US08231892B2
申请日:
2007.05.24
申请国别(地区):
US
年份:
2012
代理人:
摘要：
A drug delivery system (DDS) comprised of segmented biodegradable implants sized and suitable for implantation in an ocular region or site and methods for treating ocular conditions. The segmented implants provide an extended release of an active agent at a therapeutically effective amount for a period of time between 50 days and one year, or longer, and permit the DDS to have segments that possess individual and different drug release characteristics.
